Fanli Biotechnology (Ningbo) Co.
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- Undisclosed
Investors
- 3
About Fanli Biotechnology (Ningbo) Co.
, Ltd. is a biotechnology research and development company., Ltd. The company primarily engages in medical research and experimental development to meet the needs of clinical trials and related activities. The company's revenue is generated by providing medical research and experimental development.
Who invested in Fanli Biotechnology (Ningbo) Co.
3 investors across 2 rounds
See all investors in Fanli Biotechnology (Ningbo) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Fanli Biotechnology (Ningbo) Co.
Who invested in Fanli Biotechnology (Ningbo) Co.?
Fanli Biotechnology (Ningbo) Co. has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Fanli Biotechnology (Ningbo) Co. raised?
Fanli Biotechnology (Ningbo) Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Fanli Biotechnology (Ningbo) Co. last raise money?
Fanli Biotechnology (Ningbo) Co.'s most recent round on record is a Series A, in Jan 2026.
What does Fanli Biotechnology (Ningbo) Co. do?
Fanli Biotechnology (Ningbo) Co. is a biotechnology company.
Where is Fanli Biotechnology (Ningbo) Co. headquartered?
Fanli Biotechnology (Ningbo) Co. is headquartered in Ningbo, China.
Which VCs invest in companies like Fanli Biotechnology (Ningbo) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Fanli Biotechnology (Ningbo) Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Fanli Biotechnology (Ningbo) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.